Dianthus Therapeutics (DNTH) Depreciation and Depletion (2022 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Depreciation and Depletion came in at $27000.0 in Q3 2025, up 8.0% year-on-year from $25000.0 in Q3 2024, and down 10.0% quarter-over-quarter from $30000.0 in Q2 2025.
Dianthus Therapeutics (DNTH) Depreciation and Depletion (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $27000.0 for Q3 2025.
- On a quarterly basis, Depreciation and Depletion rose 8.0% year-over-year to $27000.0 in Q3 2025; TTM through Sep 2025 was $110000.0, a 22.22% increase from a year earlier, with the FY2024 full-year figure at $96000.0, up 43.28% from the prior year.
- Depreciation and Depletion eased to $27000.0 in Q3 2025 per DNTH's latest filing, from $30000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $30000.0 in Q2 2025 and bottomed at $6000.0 in Q3 2022.
- The 4-year median for Depreciation and Depletion is $22000.0 (2024), against an average of $20384.6.
- Across the five-year window, Depreciation and Depletion surged 216.67% in 2023 and climbed 8.0% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $11000.0 in 2022, then surged by 81.82% to $20000.0 in 2023, then rose by 30.0% to $26000.0 in 2024, then climbed by 3.85% to $27000.0 in 2025.
- Per Business Quant, the three latest DNTH Depreciation and Depletion figures stand at $27000.0 (Q3 2025), $30000.0 (Q2 2025), and $27000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |